Filter
1028
Filtered Results: 1028
Text search:
Scientific
Committee
on
AIDS
and
STI
Featured
Recommendations
76
New Publications
287
Language
Document type
No document type
739
Studies & Reports
105
Guidelines
99
Manuals
43
Strategic & Response Plan
27
Training Material
6
Fact sheets
5
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
51
Kenya
37
Global
32
South Africa
27
Nigeria
24
Uganda
23
Western and Central Europe
23
Ethiopia
21
Nepal
21
Zambia
20
Namibia
18
Tanzania
17
Bangladesh
15
Asia
15
Lesotho
14
Africa
14
Sierra Leone
13
Rwanda
13
Malawi
13
Ghana
12
Eastern Europe
12
Latin America and the Carribbean
11
Liberia
9
South–East Asia Region
9
Zimbabwe
8
Philippines
7
Botswana
7
Myanmar / Burma
7
Mozambique
6
Eswatini/ Swaziland
6
Burkina Faso
4
Senegal
4
Cameroon
4
Pakistan
4
Lebanon
4
Syria
4
Thailand
4
Indonesia
4
Ukraine
4
East and Southern Africa
4
Cambodia
3
Russia
3
USA
2
Haiti
2
Germany
2
Sudan
2
Benin
2
Sri Lanka
2
Bhutan
2
Albania
2
Armenia
2
Vietnam
2
Congo, Democratic Republic of
1
Mali
1
Morocco
1
South Sudan
1
Jordan
1
Afghanistan
1
Egypt
1
Chad
1
China
1
Papua New Guinea
1
Argentina
1
Peru
1
Brazil
1
North Macedonia
1
Hungary
1
Colombia
1
Libya
1
Madagascar
1
Mexico
1
West and Central Africa
1
North Korea
1
Timor Leste/ East Timor
1
Tajikistan
1
Uzbekistan
1
Kyrgyzstan
1
Georgia
1
Jamaica
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
374
Clinical Guidelines
87
Women & Child Health
63
Public Health
58
Key Resources
38
Capacity Building
13
Pharmacy & Technologies
9
Toolboxes
HIV
157
TB
87
Disability
73
Mental Health
70
COVID-19
31
Pharmacy
28
Global Health Education
25
Caregiver
20
Rapid Response
17
Refugee
16
Planetary Health
15
AMR
12
Health Financing Toolbox
12
NCDs
11
Ebola
10
Conflict
10
NTDs
10
Natural Hazards
8
Social Ethics
7
Polio
6
Specific Hazards
6
Zika
4
Cholera
3
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient ... sustained response to the epidemic has emerged as one of the world’s greatest challenges, and one that will be with us for the foreseeable future. Often, those countries most affected are also least able to respond, increasing their vulnerability to HIV/AIDS and in turn further complicating their ability to address the epidemic, as is the case for many nations in sub-Saharan Africa. In addition, concerns have been raised about “second wave” nations, particularly China, India, and Russia, which stand on the brink of generalized epidemics if more is not done now
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, develop...
Accessed: 07.11.2019
Stories of putting people at the centre
Accessed: 20.11.2019
This document updates the 2009 ECDC guidance on chlamydia control in Europe. It was developed by a technical expert group which conducted a critical review of the scientific evidence ... the epidemiology of chlamydia and the effectiveness of screening programmes.
The aim of this guidance is to support Member States to develop, implement or improve strategies for chlamydia control. This guidance describes the current evidence base behind the proposed options, highlights key gaps in knowledge, and suggests effective options for national chlamydia control strategies. It is directed primarily at policy advisors but should also be useful for programme managers and experts in sexual health.
Specific action sheets offer useful guidance on mental health and psychosocial support and cover the following areas coordination assessment monito...
Scant data exists on the prevalence of violence against children worldwide. However, available information, including the United Nations Secretary-General’s Study on Violence against Children, sho...
Education on the move
The main aim of these guidelines is to enable the central units of national TB and HIV/AIDS programmes to support districts to plan, coordinate and...
Summary Report on the Comprehensive Study
This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of their authors ... do not necessarily reflect the views of USAID or the United States Government.
Good practice guide
Supporting community action on HIV, health and rights to end AIDS
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 ... edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson of Country Coordinating Mechanism; Dr. Zlatko Cardaklija, HIV Coordinator for the Federation of Bosnia and Herzegovina (BiH); Dr. Nesad Seremet, Head of the HIV program, United Nations Development Program in Bosnia and Herzegovina; Ms. Gyongyver Jakab, Fund Portfolio Manager, Eastern Europe and Central Asia and Ms. Natalya Bogach, Program Officer, The Global Fund to Fight AIDS, Tuberculosis and Malaria; Dr. Nermana Mehic–Basara, Director of the Institute for Addiction Diseases of Sarajevo Canton; Mr. Denis Dedajic, Director of the Association Margina from the Federation of BiH; Mr. Srdjan Kukolj, Director of Action Against AIDS from the Republic of Srpska.
The purpose of the PAS III is to guide Pakistan’s overall national response for HIV and AIDS through 2020, through focused interventions with set targets, costs, roles ... responsibilities. The successful implementation of PAS III involves multiple stakeholders to achieve priority outcomes outlined in the Strategy. The Strategy focuses on allocating limited resources to scale up high-impact, high-value interventions such as HTC and treatment to reduce AIDS related deaths and new HIV infections. Priorities in the PAS III have been identified to ensure maximum impact in reducing new infections, especially among key populations, improving treatment uptake and retention, and improving the quality of life of people living with HIV and AIDS in the context of limited financial and human resources.
Disease Control Priorities –3rdEdition, Volume 2.
This book focuses on maternal conditions, childhood illness, and malnutrition. Specifically, the chapters address acute illness ... undernutrition in children, principally under age 5. It also covers maternal mortality, morbidity, stillbirth, and influences to pregnancy and pre-pregnancy. It also includes the transition to older childhood, in particular, the overlap and commonality with the child development volume
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South
American Society of Cardiology, aimed to formulate strategies, measures, ... actions for cardiovascular disease prevention
and rehabilitation (CVDPR). In the context of the implementation of a regional and national health policy in Latin American
countries, the goal is to promote cardiovascular health and thereby decrease morbidity and mortality. The study group on
Cardiopulmonary and Metabolic Rehabilitation from the Department of Exercise, Ergometry, and Cardiovascular Rehabilitation
of the Brazilian Society of Cardiology has created a committee of experts to review the Portuguese version of the guideline
and adapt it to the national reality.
The mission of this document is to help health professionals to adopt effective measures of CVDPR in the routine
clinical practice. The publication of this document and its broad implementation will contribute to the goal of the World
Health Organization (WHO), which is the reduction of worldwide cardiovascular mortality by 25% until 2025.
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/... prevention and treatment programmes. A number of WHO publications are available that provide a background to pharmacovigilance and, as far as possible, that material will not be repeated here. Health officials, planners, the staff of Pharmacovigilance Centres, public health teams and all health workers should become familiar with these publications, which are: • Safety of Medicines: A guide to detecting and reporting adverse drug reactions
